PT Saptausaha Gemilangindah Tbk (SAGE)
Jul 31, 2025 - SAGE was delisted (reason: acquired by SUPN)
8.68
-0.02 (-0.23%)
Inactive · Last trade price on Jul 30, 2025

Company Description

PT Saptausaha Gemilangindah Tbk develops and sells residential and commercial real estate properties in Indonesia.

The company also owns and rents properties; and provides management and consulting services. PT Saptausaha Gemilangindah Tbk was founded in 1992 and is headquartered in Jakarta Pusat, Indonesia.

PT Saptausaha Gemilangindah Tbk is a subsidiary of PT Benteng Terang Sejahtera.

PT Saptausaha Gemilangindah Tbk
Sage Therapeutics logo
CountryIndonesia
Founded1992
IPO DateJul 18, 2014
IndustryBiotechnology
SectorHealthcare
Employees353
CEOEdward Halim

Contact Details

Address:
Millennium Industrial Estate Building
Jakarta Pusat, Massachusetts 10450
Indonesia
Phone62 21 391 6338
Websitesaptagroup.com

Stock Details

Ticker SymbolSAGE
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyIDR
CIK Code0001597553
CUSIP Number78667J108
ISIN NumberUS78667J1088
SIC Code6552

Key Executives

NamePosition
Barry E. GreenePresident, Chief Executive Officer and Director
Christopher BenecchiChief Operating Officer and Treasurer
Gregory ShifermanSenior Vice President, General Counsel and Secretary
Michael Quirk Ph.D.Chief Scientific Officer and Interim Head of Research & Development
Ashley KaplowitzDirector of Investor Relations
Pamela HerbsterSenior Vice President and Chief People and Experience Officer
Dr. Helen ColquhounSenior Vice President of Drug Safety and Pharmacovigilance
Dr. Aaron Koenig M.D.Medical Director of Early Clinical Development
Helen RubinsteinInvestor Relations Officer

Latest SEC Filings

DateTypeTitle
Jul 31, 202525-NSEFiling
Jul 31, 2025SC 14D9/AFiling
Jul 31, 20258-KCurrent Report
Jul 31, 2025SC TO-T/AFiling
Jul 30, 2025SCHEDULE 13D/AFiling
Jul 30, 202510-QQuarterly Report
Jul 30, 20258-KCurrent Report
Jul 29, 2025SCHEDULE 13G/AFiling
Jul 28, 2025SC 14D9/AFiling
Jul 28, 2025SC TO-T/AFiling